Industry Partners

The ubiquitin pathway contains a plethora of novel therapeutic targets. Progenra's ability to discover novel structures with its high throughput assays has created several opportunities for establishing partnerships with other companies.

Progenra is pleased to collaborate with Ono Pharmaceuticals.

Ono logo-24657



Academic Partners

Recognizing that 1) there is still much to discover in the ubiquitin-proteasome pathway and 2) the need for rigorous validation of ubiquitin pathway targets, Progenra encourages academic laboratories to contact us with potential collaborative projects. Progenra is especially interested in prospective collaborations with translational potential.

We are pleased to have collaborations with leading national and international academic institutions including:

Brigham & Women's Hospital

Children's Hospital of Philadelphia

Chinese Academy of Sciences

Dana-Farber Cancer Institute

Emory University


Johns Hopkins University School of Medicine

Karolinska Institutet

Kumamoto University

Louisiana State University

Massachusetts General Hospital

Northwestern University

Purdue University

University of Alabama at Birmingham

University of Alberta

University of California, San Diego

University of California, Los Angeles

University of Glasgow

University of Oxford

University of Pennsylvania School of Medicine

University of Pittsburgh

University of Queensland

Virginia Tech